SCHEMBL15819473

SCHEMBL15819473

COc1cc2nc(Cc3ccccc3)nc(Cl)c2cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 1/20 0.59
▸ PDE3B Q13370 1/20 0.54
▸ PDE3A Q14432 1/20 0.54
▸ DHPS P49366 1/20 0.53
▸ MAPK1 P28482 1/20 0.51
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ ABCB1 P08183 1/20 0.49
▸ ELANE P08246 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ PDE10A Q9Y233 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ PRNP P04156 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46
▸ WHR1 P49842 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ NSD2 O96028 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15819502 0.83 NTSR1 (0.59) NTSR1PDE3BPDE3AMAPK1L3MBTL1
SCHEMBL29589930 0.79 ENPP1 (0.51) NTSR1PDE3BPDE3AMAPK1ELANE
SCHEMBL15819368 0.79 ENPP1 (0.51) NTSR1PDE3BPDE3AMAPK1ELANE
SCHEMBL2725540 0.79 ENPP1 (0.48) PDE3BPDE3AMAPK1ELANEPDE10A
SCHEMBL6119690 0.78 ENPP1 (0.44) MAPK1KMT2AELANEPDE10AKDM4E
SCHEMBL2725537 0.78 ENPP1 (0.47) PDE3BPDE3AMAPK1ELANEPDE10A
SCHEMBL2063141 0.77 ELANE (0.55) PDE3BPDE3AELANEKDM4E
SCHEMBL20509231 0.77 ELANE (0.55) ELANEKDM4E
SCHEMBL29384944 0.77 ELANE (0.55) PDE3BPDE3AELANEKDM4E
SCHEMBL1940198 0.77 ELANE (0.55) PDE3BPDE3AELANEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2938608-B1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD BURNHAM MED RES INST (US) 2021-08-04 — — EP disclosed
US-9868707-B2 Small molecule agonists of neurotensin receptor 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2018-01-16 — — US disclosed
US-20150329497-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 DUKE UNIVERSITY (US) 2015-11-19 — — US disclosed
EP-2938608-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 Sanford-Burnham Medical Research Institute (US) 2015-11-04 — — EP disclosed
WO-2014100501-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329497-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 NTSR1, NTSR2, VIPR1 NTSR1 1/4885PDE3B 1119/4885PDE3A 1122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback